Mortality rates of patients treated with drotrecogin alfa for severe sepsis based on PROWESS eligibility

E. Dodds Ashley, Richard H. Drew, M. Goodwin, D. B. May, A. Scates

Research output: Contribution to journalMeeting abstractpeer-review

Original languageAmerican English
JournalDefault journal
StatePublished - Jan 1 2007

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this